NEW YORK ( TheStreet) -- Par Pharmaceutical Companies (NYSE: PRX) hit a new 52-week high Friday as it is currently trading at $39.19, above its previous 52-week high of $39.12 with 11,544 shares traded as of 9:45 a.m. ET. Average volume has been 412,700 shares over the past 30 days. Par Pharmaceutical Companies has a market cap of $1.31 billion and is part of the health care sector and drugs industry. Shares are up 18.7% year to date as of the close of trading on Thursday. Par Pharmaceutical Companies, Inc., together with its subsidiaries, engages in developing, licensing, manufacturing, marketing, and distributing generic and branded products primarily in the United States.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter